Cyclin D1 is known to be a predictive factor for therapeutic response of colorectal carcinoma whereas cyclin D2 is required for the CDK4/6-driven growth of colorectal adenoma cells (24). The gene discussed is CDK4; the disease is colorectal carcinoma.